Addition of eicosapentaenoic acid to maintenance anti-depressant therapy in diabetes patients with major depressive disorder: a double-blind, placebo-controlled pilot study.
Completed
- Conditions
- Major depression, diabetes
- Registration Number
- NL-OMON28433
- Lead Sponsor
- Dutch Diabetes Research FoundationMinami Nutrition
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1. 18-75 years old;
2. Having diabetes;
Exclusion Criteria
1. Psychotic features;
2. History of (hypo) mania;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression.
- Secondary Outcome Measures
Name Time Method Glycemic control.